The Exchange had sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE had sought clarification from JHS Svendgaard Laboratories regarding its financial results for the quarter ended 30 June 2025 under Regulation 33 of the SEBI Listing Regulations. The company has submitted its response to the exchange. Regulation 33 deals with the submission and approval of quarterly financial results by listed companies. No specific details of the clarification query or the company's response have been disclosed in this filing.
This is a routine exchange query on financial reporting compliance. Unless the response reveals material concerns, it is unlikely to have a significant impact on shareholders or the stock price. Investors should watch for the full response to assess if any underlying issue is flagged.